<HashMap><database>biostudies-literature</database><scores/><additional><submitter>Chen Y</submitter><funding>Priority Academic Program Development of Jiangsu Higher Education Institutions</funding><pagination>8874296</pagination><full_dataset_link>https://www.ebi.ac.uk/biostudies/studies/S-EPMC7936909</full_dataset_link><repository>biostudies-literature</repository><omics_type>Unknown</omics_type><volume>2021</volume><pubmed_abstract>&lt;h4>Background&lt;/h4>Nowadays, acute intracerebral hemorrhage stroke (AICH) still causes higher mortality. Liangxue Tongyu Formula (LXTYF), originating from a traditional Chinese medicine (TCM) prescription, is widely used as auxiliary treatment for AICH.&lt;h4>Objective&lt;/h4>To dig into the multicomponent, multitarget, and multipathway mechanism of LXTYF on treating AICH via network pharmacology and RNA-seq.&lt;h4>Methods&lt;/h4>Network pharmacology analysis was used by ingredient collection, target exploration and prediction, network construction, and Gene Ontology (GO) and KEGG analysis, with the Cytoscape software and ClusterProfiler package in R. The RNA-seq data of the AICH-rats were analyzed for differential expression and functional enrichments. Herb-Compound-Target-Pathway (H-C-T-P) network w</pubmed_abstract><journal>Neural plasticity</journal><pubmed_title>Synergistic Network Pharmacology for Traditional Chinese Medicine Liangxue Tongyu Formula in Acute Intracerebral Hemorrhagic Stroke.</pubmed_title><pmcid>PMC7936909</pmcid><funding_grant_id>BK20161575</funding_grant_id><funding_grant_id>81373512</funding_grant_id><pubmed_authors>Yang X</pubmed_authors><pubmed_authors>Li W</pubmed_authors><pubmed_authors>Li G</pubmed_authors><pubmed_authors>Wang P</pubmed_authors><pubmed_authors>Dong J</pubmed_authors><pubmed_authors>Wang F</pubmed_authors><pubmed_authors>Chen Y</pubmed_authors><pubmed_authors>Qian Q</pubmed_authors><pubmed_authors>Yang D</pubmed_authors><pubmed_authors>Shen X</pubmed_authors></additional><is_claimable>false</is_claimable><name>Synergistic Network Pharmacology for Traditional Chinese Medicine Liangxue Tongyu Formula in Acute Intracerebral Hemorrhagic Stroke.</name><description>&lt;h4>Background&lt;/h4>Nowadays, acute intracerebral hemorrhage stroke (AICH) still causes higher mortality. Liangxue Tongyu Formula (LXTYF), originating from a traditional Chinese medicine (TCM) prescription, is widely used as auxiliary treatment for AICH.&lt;h4>Objective&lt;/h4>To dig into the multicomponent, multitarget, and multipathway mechanism of LXTYF on treating AICH via network pharmacology and RNA-seq.&lt;h4>Methods&lt;/h4>Network pharmacology analysis was used by ingredient collection, target exploration and prediction, network construction, and Gene Ontology (GO) and KEGG analysis, with the Cytoscape software and ClusterProfiler package in R. The RNA-seq data of the AICH-rats were analyzed for differential expression and functional enrichments. Herb-Compound-Target-Pathway (H-C-T-P) network w</description><dates><release>2021-01-01T00:00:00Z</release><publication>2021</publication><modification>2025-04-04T18:38:16.184Z</modification><creation>2025-04-04T18:38:16.184Z</creation></dates><accession>S-EPMC7936909</accession><cross_references><pubmed>33727915</pubmed><doi>10.1155/2021/8874296</doi></cross_references></HashMap>